日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/08/21 | 3,449 | 3,510 | 3,420 | 3,437 | -57 | -1.6% | 391,000 |
| 2024/08/20 | 3,428 | 3,510 | 3,414 | 3,494 | +127 | +3.8% | 314,100 |
| 2024/08/19 | 3,394 | 3,424 | 3,345 | 3,367 | -17 | -0.5% | 365,000 |
| 2024/08/16 | 3,375 | 3,416 | 3,338 | 3,384 | +57 | +1.7% | 431,800 |
| 2024/08/15 | 3,321 | 3,341 | 3,303 | 3,327 | -14 | -0.4% | 272,200 |
| 2024/08/14 | 3,392 | 3,420 | 3,324 | 3,341 | -52 | -1.5% | 315,400 |
| 2024/08/13 | 3,254 | 3,397 | 3,250 | 3,393 | +156 | +4.8% | 597,500 |
| 2024/08/09 | 3,259 | 3,375 | 3,204 | 3,237 | -39 | -1.2% | 773,200 |
| 2024/08/08 | 3,378 | 3,378 | 3,213 | 3,276 | +248 | +8.2% | 912,400 |
| 2024/08/07 | 3,005 | 3,148 | 2,964 | 3,028 | -47 | -1.5% | 542,900 |
| 2024/08/06 | 3,012 | 3,193 | 3,011 | 3,075 | +174.5 | +6% | 534,100 |
| 2024/08/05 | 3,047 | 3,129 | 2,875 | 2,900.5 | -327.5 | -10.1% | 710,400 |
| 2024/08/02 | 3,287 | 3,295 | 3,222 | 3,228 | -146 | -4.3% | 371,600 |
| 2024/08/01 | 3,400 | 3,423 | 3,355 | 3,374 | -75 | -2.2% | 214,600 |
| 2024/07/31 | 3,460 | 3,482 | 3,424 | 3,449 | ±0 | ±0% | 457,000 |
| 2024/07/30 | 3,452 | 3,470 | 3,414 | 3,449 | -3 | -0.1% | 295,900 |
| 2024/07/29 | 3,442 | 3,481 | 3,442 | 3,452 | +29 | +0.8% | 221,700 |
| 2024/07/26 | 3,458 | 3,503 | 3,421 | 3,423 | +8 | +0.2% | 277,900 |
| 2024/07/25 | 3,440 | 3,455 | 3,406 | 3,415 | +9 | +0.3% | 373,100 |
| 2024/07/24 | 3,428 | 3,447 | 3,363 | 3,406 | -47 | -1.4% | 322,800 |
| 2024/07/23 | 3,440 | 3,466 | 3,427 | 3,453 | +8 | +0.2% | 247,400 |
| 2024/07/22 | 3,469 | 3,472 | 3,432 | 3,445 | -15 | -0.4% | 182,800 |
| 2024/07/19 | 3,470 | 3,470 | 3,421 | 3,460 | -4 | -0.1% | 224,500 |
| 2024/07/18 | 3,435 | 3,472 | 3,413 | 3,464 | +11 | +0.3% | 425,800 |
| 2024/07/17 | 3,517 | 3,517 | 3,440 | 3,453 | -36 | -1% | 312,300 |
| 2024/07/16 | 3,575 | 3,578 | 3,478 | 3,489 | -75 | -2.1% | 386,400 |
| 2024/07/12 | 3,536 | 3,582 | 3,536 | 3,564 | +20 | +0.6% | 308,300 |
| 2024/07/11 | 3,490 | 3,554 | 3,470 | 3,544 | +92 | +2.7% | 460,100 |
| 2024/07/10 | 3,434 | 3,456 | 3,415 | 3,452 | +12 | +0.3% | 237,100 |
| 2024/07/09 | 3,410 | 3,448 | 3,383 | 3,440 | +32 | +0.9% | 333,600 |
| 2024/07/08 | 3,399 | 3,419 | 3,380 | 3,408 | +20 | +0.6% | 257,900 |
| 2024/07/05 | 3,410 | 3,410 | 3,371 | 3,388 | -2 | -0.1% | 246,200 |
| 2024/07/04 | 3,400 | 3,411 | 3,380 | 3,390 | +17 | +0.5% | 326,100 |
| 2024/07/03 | 3,327 | 3,373 | 3,326 | 3,373 | +34 | +1% | 366,600 |
| 2024/07/02 | 3,330 | 3,345 | 3,286 | 3,339 | +14 | +0.4% | 465,400 |
| 2024/07/01 | 3,298 | 3,328 | 3,263 | 3,325 | +70 | +2.2% | 401,100 |
| 2024/06/28 | 3,240 | 3,274 | 3,234 | 3,255 | +29 | +0.9% | 480,100 |
| 2024/06/27 | 3,170 | 3,229 | 3,169 | 3,226 | +33 | +1% | 352,800 |
| 2024/06/26 | 3,194 | 3,219 | 3,177 | 3,193 | -14 | -0.4% | 281,500 |
| 2024/06/25 | 3,186 | 3,227 | 3,177 | 3,207 | +38 | +1.2% | 306,100 |
| 2024/06/24 | 3,167 | 3,218 | 3,164 | 3,169 | +38 | +1.2% | 377,600 |
| 2024/06/21 | 3,157 | 3,178 | 3,121 | 3,131 | -29 | -0.9% | 604,800 |
| 2024/06/20 | 3,123 | 3,175 | 3,116 | 3,160 | +22 | +0.7% | 336,200 |
| 2024/06/19 | 3,101 | 3,138 | 3,101 | 3,138 | -23 | -0.7% | 329,800 |
| 2024/06/18 | 3,200 | 3,215 | 3,156 | 3,161 | -51 | -1.6% | 336,100 |
| 2024/06/17 | 3,190 | 3,224 | 3,133 | 3,212 | +22 | +0.7% | 484,900 |
| 2024/06/14 | 3,120 | 3,205 | 3,113 | 3,190 | +67 | +2.1% | 567,100 |
| 2024/06/13 | 3,160 | 3,160 | 3,111 | 3,123 | -43 | -1.4% | 427,100 |
| 2024/06/12 | 3,118 | 3,168 | 3,095 | 3,166 | +26 | +0.8% | 454,100 |
| 2024/06/11 | 3,080 | 3,154 | 3,073 | 3,140 | -8 | -0.3% | 436,700 |
151～
200
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 350,400円 | +7.9% | +8.9% | 3.54% | 7.50倍 | 1.00倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 193,900円 | +5.0% | +1.5% | 0.00% | 16.65倍 | 4.43倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 住友ファーマ | 62,100円 | +21.1% | - | 0.00% | 15.42倍 | 2.16倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| 科研薬 | 444,100円 | +22.8% | +113.0% | 4.28% | 12.34倍 | 1.10倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 371,500円 | +14.5% | -2.3% | 2.42% | 13.59倍 | 0.72倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム
